Preferred Label : moxisylyte;

MeSH definition : An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312);

MeSH synonym : acetoxythymoxamine; thymoxamine; thymoxyalcylamine;

CISMeF synonym : viatris brand of moxisylyte hydrochloride; hansam brand of moxisylyte hydrochloride; arkopharma brand of moxisylyte hydrochloride;

DeCS synonym : Carlyt ne;

MeSH hyponym : carlytène; moxisylyte hydrochloride; opilon brand of moxisylyte hydrochloride; icavex; Hydrochloride, Moxisylyte;

MeSH CAS label : phenol, 4-(2-(dimethylamino)ethoxy)-2-methyl-5-(1-methylethyl)-, acetate (ester);

MeSH Related Number : 54-32-0 (Moxisylyte); moxisylyte hydrochloride; WK2KZM9V6X;

Registry Number MeSH : 54-32-0;

Related CAS MeSH : WK2KZM9V6X (Moxisylyte hydrochloride);

Codes EINECS : 200-204-1;

Is substance : O;

UNII : PW8QYA7KI0;

InChIKey : VRYMTAVOXVTQEF-UHFFFAOYSA-N;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :

An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)

http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-11/carlytene_02-11-2011_avis_ct-11263.pdf
http://www.has-sante.fr/portail/jcms/c_1121578/carlytene
2011
France
French
administration, oral
treatment outcome
insurance, health, reimbursement
moxisylyte
moxisylyte hydrochloride
vasodilator agents
moxisylyte
cognition disorders
aged
raynaud disease
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-4905_carlytene.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_618878
2007
France
French
moxisylyte
insurance, health, reimbursement
administration, oral
cognition disorders
aged
raynaud disease
vasodilator agents
moxisylyte
tablets
evaluation of the transparency committee

---
Nous contacter.
27/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.